bg
A

Amylyx Pharmaceuticals (AMLX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Comp... Read more

  • USD18.33
  • USD18.37
  • USD18.03
  • USD41.93
  • -8.20%
  • 192M
  • 323.36k
  • 872.27k
  • 1.3B
  • 18.49
  • -37.80%
  • 8.30%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.